{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T20:40:02Z","timestamp":1730666402744,"version":"3.28.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,3]]},"DOI":"10.7759\/cureus.72936","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T20:00:16Z","timestamp":1730664016000},"source":"Crossref","is-referenced-by-count":0,"title":["Serratia marcescens Prosthetic Valve Endocarditis: Portending a Dismal Course"],"prefix":"10.7759","author":[{"given":"Selma","family":"Siagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najlaa","family":"Belharty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasna","family":"Rami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawal","family":"Doghmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Cherti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study","volume":"169","author":"Murdoch DR","year":"2009","unstructured":"Murdoch DR, Corey GR, Hoen B, et al.. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009, 169:463-73. 10.1001\/archinternmed.2008.603","journal-title":"Arch Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad271","article-title":"The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria","volume":"77","author":"Fowler VG","year":"2023","unstructured":"Fowler VG, Durack DT, Selton-Suty C, et al.. The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria. Clin Infect Dis. 2023, 77:518-26. 10.1093\/cid\/ciad271","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado V","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, et al.. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023, 44:3948-4042. 10.1093\/eurheartj\/ehad193","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.24.3022","article-title":"Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota","volume":"293","author":"Tleyjeh IM","year":"2005","unstructured":"Tleyjeh IM, Steckelberg JM, Murad HS, et al.. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005, 293:3022-8. 10.1001\/jama.293.24.3022","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-12-200712180-00002","article-title":"Non-HACEK gram-negative Bacillus endocarditis","volume":"147","author":"Morpeth S","year":"2007","unstructured":"Morpeth S, Murdoch D, Cabell CH, et al.. Non-HACEK gram-negative Bacillus endocarditis. Ann Intern Med. 2007, 147:829-35. 10.7326\/0003-4819-147-12-200712180-00002","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14399","article-title":"Serratia marcescens antibiotic resistance mechanisms of an opportunistic pathogen: a literature review","volume":"11","author":"Tavares-Carreon F","year":"2023","unstructured":"Tavares-Carreon F, De Anda-Mora K, Rojas-Barrera IC, Andrade A. Serratia marcescens antibiotic resistance mechanisms of an opportunistic pathogen: a literature review. PeerJ. 2023, 11:e14399. 10.7717\/peerj.14399","journal-title":"PeerJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1951.03810100045004","article-title":"Infection due to chromobacteria; report of eleven cases","volume":"88","author":"Wheat RP","year":"1951","unstructured":"Wheat RP, Zuckerman A, Rantz LA. Infection due to chromobacteria; report of eleven cases. AMA Arch Intern Med. 1951, 88:461-6. 10.1001\/archinte.1951.03810100045004","journal-title":"AMA Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-1-29","article-title":"Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse","volume":"84","author":"Mills J","year":"1976","unstructured":"Mills J, Drew D. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med. 1976, 84:29-35. 10.7326\/0003-4819-84-1-29","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1980.00330140057018","article-title":"Serratia endocarditis. A follow-up report","volume":"140","author":"Cooper R","year":"1980","unstructured":"Cooper R, Mills J. Serratia endocarditis. A follow-up report. Arch Intern Med. 1980, 140:199-202.","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02208-17","article-title":"Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort","volume":"62","author":"Falcone M","year":"2018","unstructured":"Falcone M, Tiseo G, Durante-Mangoni E, et al.. Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort. Antimicrob Agents Chemother. 2018, 62:e02208-17. 10.1128\/AAC.02208-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0036933013482647","article-title":"Bilateral endogenous Serratia marcescens endophthalmitis secondary to endocarditis following cardiac surgery","volume":"58","author":"Lyall DA","year":"2013","unstructured":"Lyall DA, Gregory ME, McDonnell J, De Villiers F, Tejwani D. Bilateral endogenous Serratia marcescens endophthalmitis secondary to endocarditis following cardiac surgery. Scott Med J. 2013, 58:e1-6. 10.1177\/0036933013482647","journal-title":"Scott Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.02.2009.1608","article-title":"Pacemaker endocarditis: an important clinical entity","volume":"2009","author":"De Silva K","year":"2009","unstructured":"De Silva K, Fife A, Murgatroyd F, Gall N. Pacemaker endocarditis: an important clinical entity. BMJ Case Rep. 2009, 2009:bcr02.2009.1608. 10.1136\/bcr.02.2009.1608","journal-title":"BMJ Case Rep"},{"key":"ref13","article-title":"Serratia marcescens prosthetic mitral valve endocarditis associated with hemolytic anemia. [Article in Japanese]","volume":"45","author":"Kochi K","year":"1997","unstructured":"Kochi K, Yokote Y, Kyo S, Ueda K, Omoto R. Serratia marcescens prosthetic mitral valve endocarditis associated with hemolytic anemia. [Article in Japanese]. Nihon Kyobu Geka Gakkai Zasshi. 1997, 45:860-4.","journal-title":"Nihon Kyobu Geka Gakkai Zasshi"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour LM","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, et al.. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015, 132:1435-86. 10.1161\/CIR.0000000000000296","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184203-serratia-marcescens-prosthetic-valve-endocarditis-portending-a-dismal-course","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T20:00:17Z","timestamp":1730664017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184203-serratia-marcescens-prosthetic-valve-endocarditis-portending-a-dismal-course"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,3]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.72936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2024,11,3]]}}}